Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Alendronate sodium
Sponsor: Barwon Health
Collaborators: AstraZeneca